Inspire Investing LLC Acquires 62 Shares of Balchem Co. (NASDAQ:BCPC)

Inspire Investing LLC increased its holdings in shares of Balchem Co. (NASDAQ:BCPC) by 2.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,348 shares of the basic materials company’s stock after buying an additional 62 shares during the period. Inspire Investing LLC’s holdings in Balchem were worth $413,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the business. Bessemer Group Inc. lifted its stake in shares of Balchem by 568.9% in the 1st quarter. Bessemer Group Inc. now owns 301 shares of the basic materials company’s stock valued at $47,000 after purchasing an additional 256 shares during the period. GAMMA Investing LLC lifted its stake in Balchem by 18.0% in the first quarter. GAMMA Investing LLC now owns 473 shares of the basic materials company’s stock valued at $73,000 after buying an additional 72 shares during the period. TD Asset Management Inc acquired a new position in shares of Balchem during the 2nd quarter worth about $200,000. Heritage Family Offices LLP acquired a new position in shares of Balchem during the 2nd quarter worth about $206,000. Finally, Sage Rhino Capital LLC bought a new stake in shares of Balchem in the 2nd quarter valued at about $207,000. 87.91% of the stock is currently owned by institutional investors and hedge funds.

Balchem Trading Up 1.0 %

NASDAQ:BCPC opened at $173.78 on Thursday. The company has a debt-to-equity ratio of 0.26, a current ratio of 2.83 and a quick ratio of 1.79. The business’s 50-day simple moving average is $170.97 and its 200-day simple moving average is $161.38. Balchem Co. has a fifty-two week low of $110.74 and a fifty-two week high of $186.03. The stock has a market capitalization of $5.63 billion, a PE ratio of 49.09, a price-to-earnings-growth ratio of 5.43 and a beta of 0.65.

Balchem (NASDAQ:BCPC) last released its quarterly earnings results on Friday, July 26th. The basic materials company reported $0.98 earnings per share for the quarter, beating the consensus estimate of $0.95 by $0.03. Balchem had a net margin of 12.52% and a return on equity of 10.94%. The company had revenue of $234.08 million during the quarter, compared to analysts’ expectations of $241.26 million. Sell-side analysts expect that Balchem Co. will post 3.96 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

BCPC has been the subject of a number of analyst reports. HC Wainwright boosted their price objective on shares of Balchem from $170.00 to $185.00 and gave the company a “buy” rating in a report on Wednesday, July 31st. StockNews.com cut shares of Balchem from a “buy” rating to a “hold” rating in a research report on Monday, July 29th.

Insider Buying and Selling

In other news, SVP Gunsteren Job Leonard Van sold 7,750 shares of the business’s stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $180.05, for a total value of $1,395,387.50. Following the sale, the senior vice president now directly owns 8,540 shares in the company, valued at $1,537,627. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 1.25% of the company’s stock.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.